Found 9 matching trials
Efficacy and Safety of CKD-501 Added to D150 Plus D745 25mg Therapy in Patients With Type 2 Diabetes
PHASE3The purpose of this study is to prove that the group treated with CKD-501 i...
Location
Severance Hospital, Yonsei University Health System
Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic of CKD-501, D745, and D150 for Healthy Subjects in Fed State.
PHASE1This is a Randomized, open-label, single oral dosing, two-sequence, and two...
Location
Chung-Ang University Gwangmyeong Hospital
Efficacy and Safety of CKD-501 Added to D150 Plus D745 10mg Therapy in Patients With Type 2 Diabetes
PHASE3The purpose of this study is to prove that the group treated with CKD-501 i...
Location
Severance Hospital, Yonsei University Health System
A Clinical Trial to Evaluate the Pharmacokinetic Profiles and Safety of CKD-383.
PHASE1A clinical trial to evaluate the pharmacokinetic profiles and safety of CKD...
Location
Severance Hospital
A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction and Safety of CKD-501, D745 and D150
PHASE1A Clinical trial to investigate the pharmacokinetic drug interaction and sa...
Location
Severance Hospital
Evaluate the Drug-drugs Interaction Between Lobeglitazone 0.5mg and Empagliflozin 25mg
PHASE1A Clinical Trial to evaluate the Pharmacokinetics and Tolerability of CKD-3...
Location
Chonbuk National University Hospital
Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-383 0.5/25/1000mg in Healthy Volunteers
PHASE1This study is a randomized, open-label, single dose, crossover study to eva...
Location
H Plus Yangji Hospital
Evaluate the Pharmacokinetics and Safety Between the Treatment of CKD-383 and Treatment of CKD-501, D745, D150, and D029
PHASE1Evaluate the Pharmacokinetics and Safety Between the Administration of CKD-...
Location
CHA Bundang Medical Center, CHA University
Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-383 0.25/12.5/1000mg in Healthy Volunteers
PHASE1This study is a randomized, open-label, single dose, crossover study to eva...
Location
H Plus Yangji Hospital